南美和中美心脏移植市场预测至 2030 年 - 区域分析 - 按手术类型(原位心脏移植和异位心脏移植)、类型(供体活体心脏和人工心脏)和最终用户(医院、心脏中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 55    |    Report Code: BMIRE00030081    |    Category: Life Sciences

South & Central America Heart Transplant Market
预计南美和中美心脏移植市场将从 2022 年的 6.1118 亿美元增长到 2030 年的 13.1597 亿美元。预计从 2022 年到 2030 年,该市场的复合年增长率为 10.1%。

AI 在移植程序中的应用推动了南美和中美心脏移植市场的发展

由人工智能 (AI) 支持的独特设计的系统有助于检测心脏移植后宿主排斥的早期迹象和严重程度。心内膜心肌活检 (EMB) 筛查是识别心脏移植后同种异体移植排斥的护理标准。2022 年,一种新的 AI 系统被设计出来,称为心脏排斥评估神经估计器 (CRANE),可与医学评估结合使用,实现快速准确的诊断。CRANE 还有助于减少宿主体内心脏排斥的存在和严重程度的差异。它是一个基于深度学习的 AI 系统,用于自动评估从 EMB 获得的千兆像素全幻灯片图像。2020 年,美国国立卫生研究院拨款 320 万美元用于探索 AI 在心脏移植中的能力。利用这笔资助,来自佩雷尔曼医学院(宾夕法尼亚大学)、凯斯西储大学、克利夫兰诊所和雪松西奈医学中心的研究人员旨在研究导致新心脏排斥的原因以及如何处理它。他们使用 AI 分析心脏活检组织图像,发现在新心脏排斥中起重要作用的免疫细胞类型。因此,在未来几年,在心脏移植程序中采用 AI 可能会为市场带来新的趋势。

南美和中美心脏移植市场概览

南美和中美的心脏移植市场细分为巴西、阿根廷和南美和中美其他地区。医疗设施的发展、高血压发病率的上升、老年人口的增加以及肾脏和心脏疾病发病率的激增是预计推动南美和中美心脏移植市场发展的因素。超过一半的拒绝(59%)是由于捐赠者的临床状况,包括年老、合并症和感染。据巴西政府称,2021 年 1 月至 11 月,巴西进行了 12,000 多例器官移植。儿童也受到严重影响。2022 年,583 名 0-17 岁儿童接受了器官移植手术,与 2021 年相同。约 641 名新儿童进入候补名单,66 人在等待器官时死亡。

南美和中美心脏移植市场收入和预测到 2030 年(百万美元)

南美和中美心脏移植市场细分

南美和中美心脏移植市场细分为手术类型、类型、最终用户和国家。

根据手术类型,南美和中美心脏移植市场分为原位心脏移植和异位心脏移植。2022 年,原位心脏移植部分在南美和中美心脏移植市场中占有较大份额。

就类型而言,南美和中美心脏移植市场分为供体活体心脏和人工心脏。2022 年,供体活体心脏部分在南美和中美心脏移植市场中占有较大份额。此外,人工心脏部分分为心室辅助装置和全人工心脏。

根据最终用户,南美和中美心脏移植市场分为医院、心脏中心和其他。2022 年,医院部分在南美和中美心脏移植市场中占有最大份额。

根据国家/地区,南美和中美心脏移植市场分为巴西、阿根廷和南美和中美洲其他地区。 2022 年,巴西在南美和中美心脏移植市场占据主导地位。

Terumo Corp、Abbott Laboratories、SynCardia Systems LLC、LivaNova Plc 和 Calon Cardio-Technology Ltd 是南美和中美心脏移植市场的一些领先公司。

South & Central America Heart Transplant Strategic Insights

Strategic insights for South & Central America Heart Transplant involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-heart-transplant-market-strategic-framework.webp
Get more information on this report

South & Central America Heart Transplant Report Scope

Report Attribute Details
Market size in 2022 US$ 611.18 Million
Market Size by 2030 US$ 1,315.97 Million
Global CAGR (2022 - 2030) 10.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 手术类型
  • 原位心脏移植和异位心脏移植
By 类型
  • 供体活体心脏和人工心脏
By 最终用户
  • 医院
  • 心脏中心
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • LivaNova Plc
  • Get more information on this report

    South & Central America Heart Transplant Regional Insights

    The regional scope of South & Central America Heart Transplant refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-heart-transplant-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Heart Transplant Market

    1. Terumo Corp

    2. Abbott Laboratories

    3. SynCardia Systems LLC

    4. LivaNova Plc

     

    Frequently Asked Questions
    How big is the South & Central America Heart Transplant Market?

    The South & Central America Heart Transplant Market is valued at US$ 611.18 Million in 2022, it is projected to reach US$ 1,315.97 Million by 2030.

    What is the CAGR for South & Central America Heart Transplant Market by (2022 - 2030)?

    As per our report South & Central America Heart Transplant Market, the market size is valued at US$ 611.18 Million in 2022, projecting it to reach US$ 1,315.97 Million by 2030. This translates to a CAGR of approximately 10.1% during the forecast period.

    What segments are covered in this report?

    The South & Central America Heart Transplant Market report typically cover these key segments-

  • 手术类型 (原位心脏移植和异位心脏移植)
  • 类型 (供体活体心脏和人工心脏)
  • 最终用户 (医院, 心脏中心)
  • What is the historic period, base year, and forecast period taken for South & Central America Heart Transplant Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Heart Transplant Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in South & Central America Heart Transplant Market?

    The South & Central America Heart Transplant Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • LivaNova Plc
  • Who should buy this report?

    The South & Central America Heart Transplant Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Heart Transplant Market value chain can benefit from the information contained in a comprehensive market report.